Table 2.
Diagnoses According to Method.
Diagnosis | Patients with Complete Evaluation (N = 382) |
---|---|
no./total no. (%) | |
Diagnosis by any method | 132/382 (35) |
Clinical review | 15/132 (11) |
Directed clinical testing | 14/132 (11) |
Nonsequencing genomewide diagnostic assay | 5/132 (4) |
Exome or genome sequencing* | 98/132 (74) |
Reanalysis of previously obtained sequencing data | 11/132 (8) |
Exome sequencing through the UDN | 55/132 (42) |
Had previously undergone exome sequencing | 6/132 (5) |
Genome sequencing through the UDN | 32/132 (24) |
Had previously undergone exome sequencing | 17/132 (13) |
No diagnosis | 250/382 (65) |
One diagnosis was established by both exome and genome sequencing.